NCT05771077 is a Phase 1 clinical trial of Poly(Amidoamine) dendrimer in White Spot Lesion, sponsored by Egymedicalpedia.

Who is sponsoring NCT05771077?

NCT05771077 is sponsored by Egymedicalpedia.

What drugs are being tested in NCT05771077?

Interventions in NCT05771077: Poly(Amidoamine) dendrimer.

What condition does NCT05771077 study?

NCT05771077 studies White Spot Lesion.

Is NCT05771077 still recruiting?

NCT05771077 is currently completed. Last updated 16 March 2023.

Last reviewed 2023-03-16 · How we verify

NCT05771077

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Poly Amido Amine Dendrimer, Nano-hydroxyapatite

Completed Phase 1 Last updated 16 March 2023

What this trial tests

Phase 1 trial testing Poly(Amidoamine) dendrimer in White Spot Lesion in 45 participants. Completed in 15 December 2022.

Timeline

1 June 2022

Primary endpoint
1 December 2022

15 December 2022

Quick facts

Lead sponsor	Egymedicalpedia
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	45
Start date	1 June 2022
Primary completion	1 December 2022
Estimated completion	15 December 2022
Sites	1 location across Egypt

Drugs / interventions tested

Poly(Amidoamine) dendrimer — full drug profile →

Conditions studied

White Spot Lesion — all drugs for White Spot Lesion →

Sponsor

Egymedicalpedia — full company profile →

Who can join

Adults 16 to 25, any sex, with White Spot Lesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dental caries is a common oral disease. The process of caries formation is a cycle of remineralization and demineralization with various stages being either reversible or irreversible.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for White Spot Lesion

Currently open trials in the same condition.

NCT07319884 — The Role of Fluoride Varnish Application in Preventing White Spot Lesions During Clear Aligner Treatment: A Controlled S · NA · active not recruiting

Other Egymedicalpedia trials

Trials by the same sponsor.

NCT06590818 — The Effect of Body Mass Index on Short-term Results of HTO · NA · recruiting
NCT06583811 — Remifentanil and Remimazolam to Limit Patient Movement · NA · recruiting
NCT06522984 — Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid · NA · recruiting
NCT06370078 — Effect of Early Administration of Albumin 20% Versus Crystalloid · NA · recruiting
NCT06370221 — The Effect of Psoriatic Arthritis on Female Sexual Dysfunction · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05771077 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Egymedicalpedia
Last refreshed: 16 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05771077.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing